Development

INSIGHTS ON DRUG DEVELOPMENT

Rethinking Design, Cost, And Scalability In Biomanufacturing
Life science teams increasingly need tools that scale, simplify workflows, and reduce operational costs. Examine how emerging instrumentation focuses on usability, performance, and manufacturability.
Inside Asymchem's Advanced R&D Capabilities In The UK
Advanced experimentation, unified workflows, and continuous manufacturing are accelerating small‑molecule development, improving insight and creating more efficient paths from discovery to scale.
Walk-Away Monitoring Of Cytotoxicity, Viability, And Apoptosis
Real-time cell health monitoring reveals how drug dose and timing impact apoptosis, necrosis, and viability. Explore how automated workflows help pinpoint mechanistic toxicity windows.
Functional Characterization Of 3D Assembled Neurospheres
Neural organoids and 3D spheroids offer advanced platforms for brain research and drug discovery. Discover how creating 3D neurospheres from iPSC-derived neurons and astrocytes aids in compound profiling and toxicity testing.

Accelerating The Study Of Viral Infection And Therapeutics
8/7/2024

Explore the utilization of the Organ-Chips for investigating viral infections and expediting the development of new therapeutics.
Choosing The Best Amorphous Dispersion Path Before It Costs You
6/22/2026

Parallel screening across multiple solid dispersion platforms early optimizes drug solubility and stability, building a strong technical foundation that prevents costly development delays.
Cross-Site Work Within Cambrex's Network
7/24/2026

Matthew Zart, Group Leader of Analytical Development, on what happens when a method arrives from another site — inheriting Phase II work from High Point and getting it commercial-ready for the QC lab.
Solving Formulation Challenges Across Modalities
6/15/2026

Optimize drug delivery by leveraging advanced nanoparticle engineering to dramatically increase small-molecule oral drug loading and enable ultra-high-concentration subcutaneous formulations.
Liberate Your Workflow: Flexible, Multi-Technique Chemical Data Analysis
6/17/2026

Scientific workflows are no longer confined to one device. Cross-platform access to analytical data is becoming essential, helping researchers stay productive and collaborate more effectively.

CD34+ HSC LNP Kits

Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.
Peptide Development Strategies

Peptides occupy a therapeutic niche between small molecules and large biologics. We understand the fundamental physiological challenges to peptide delivery and that there is no “one-size-fits-all” approach for formulation design.
Solid Form Services

We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program.
Gain Human-Relevant Insights With Patient-Derived Assay-Ready Organoids

3D organoids offer enhanced physiological relevance and are ready to use from cryopreserved vials. Discover how they can streamline your research with high-quality and comprehensive support.
High-Quality, Cost-Effective and Reliable CDMO Solutions

End-to-end pharma manufacturing support unites development expertise and scalable production to accelerate the path from formulation to commercial supply with quality and flexibility.